⌕

Boston Scientific (BSX) vs Humana (HUM)

Your goal
● Balanced style: every factor counts equally.
#1 FIT · LEADS
63
Humana Inc.
$461.25 · $55B · as of last close
Street favoriteBest income
of the stocks compared here

The front-runner. Leads the balanced score. Its widest win over the field is analyst sentiment.

#2 FIT
58
Boston Scientific Corp.
$43.69 · $63B · as of last close
Fastest growerHighest qualityCheapest
of the stocks compared here

The challenger. Trails the leader on the balanced score. Its widest win over the field is growth.

HUM edges ahead (63/100 vs BSX 58) under a balanced style, mostly on analyst sentiment. But BSX wins on growth, so the comparison turns on what you weight. Switch your goal above and watch the scores move.

THE SCORECARD · FACTOR BY FACTOR · the best value in each row is ticked, and a tie ticks every tied column · weight bar shows how much it counts for your goal

FactorBSXHUM
Overall fit score
weighted for your balanced goal
58
✓ 63
Valuation
Cheaper for what you get
1×
✓ P/E 18 · EV/EBITDA 13.9
P/E trailing
69
P/E 44 · EV/EBITDA 13.6
P/E trailing
61
Growth
Revenue & earnings momentum
1×
✓ —
72
—
30
Profitability & quality
Margins & return on capital
1×
✓ Net 17% · ROIC 10%
TTM through Sep 30, 2026
64
Net 1% · ROIC 6%
TTM through Sep 30, 2026
55
Total return
Share-price change with dividends reinvested
1×
5Y +0%/yr
52
✓ 5Y +1%/yr
54
Risk (calm = better)
Volatility & drawdown
1×
✓ β 0.5 · DD −62%
82
β 0.4 · DD −70%
75
Balance sheet†
Debt vs cash cushion
1×
Net debt/EBITDA 2.1×
TTM through Sep 30, 2026
33
✓ Net debt/EBITDA −4.0×
TTM through Sep 30, 2026
41
Dividend & income
Cash paid to you
1×
—
41
✓ 0.77% yield· A
89
Analyst sentiment
Forward EPS growth (consensus)
1×
Est EPS −1%/yr · 16 analysts
48
✓ Est EPS +95%/yr · 15 analysts
100
† Balance sheet is scored on 5 peer percentiles (current ratio, quick ratio, net debt/EBITDA, interest coverage and debt/equity). The cell shows one of them, so a column can lead on the printed number and still lose the row.
The letter beside the dividend yield is our dividend-safety grade (A+ to F), a read on how likely that dividend is to be cut. It does not grade the yield.
Loading chart…
WHERE EACH ONE IS STRONG
GrowthValueQualityReturnSafetyIncome
■ BSX■ HUM
CAN YOU STOMACH THE RIDE?
Worst drawdown3-year beta vs S&P 500VolatilityHistory
BSX−62%0.5427%5Y
HUM−70%0.3939%5Y
Drawdown and volatility are measured over five years on the same total return as the chart, dividends reinvested.
THE CASE FOR & AGAINST EACH
BULL CASE

▲ Leads on growth: — (score 72).

▲ Leads on profitability & quality: Net 17% · ROIC 10% (score 64).

BEAR CASE

▼ Weakest on analyst sentiment: Est EPS −1%/yr · 16 analysts (score 48).

▼ Weakest on dividend & income: — (score 41).

BULL CASE

▲ Leads on analyst sentiment: Est EPS +95%/yr · 15 analysts (score 100).

▲ Leads on dividend & income: 0.77% yield (score 89).

BEAR CASE

▼ Weakest on growth: — (score 30).

▼ Weakest on profitability & quality: Net 1% · ROIC 6% (score 55).

WHAT COULD CHANGE THE SCORE
Balance sheetCurrently 33/100 (Net debt/EBITDA 2.1×). Taking it to 100 would lift the balanced score by 8 points, the biggest single move available.
Dividend & incomeCurrently 41/100 (—). Taking it to 100 would lift the balanced score by 7 points, the next biggest.
GrowthCurrently 30/100 (—). Taking it to 100 would lift the balanced score by 9 points, the biggest single move available.
Balance sheetCurrently 41/100 (Net debt/EBITDA −4.0×). Taking it to 100 would lift the balanced score by 8 points, the next biggest.
Scores are Tenet composites, 0–100, reweighted for your selected goal. Seven of the eight factors are sector percentiles; analyst sentiment is an absolute curve on forward EPS growth, capped at 100, so two very high-growth names can share the top score. Moat/durability is not scored (qualitative, not measurable). Comparison is decision-support, not a recommendation · past performance does not predict future returns · Not investment advice · prices are each company's own latest close, the newest here being Nov 16, 2026 · valuation, growth, quality and balance scores from the Nov 16, 2026 scoring run · analyst consensus, return, risk and income scores computed Nov 16, 2026.

Install Tenet on your phone

Tenet home pageMethodology© 2026 Tenet Investing Inc.

Data from Intrinio and Financial Modeling Prep.